Cheng Yong, Wei Feng, Yu Hongkun, Ling Xueying, Guo Bin, Shang JingJie, Cai Qijun, Li Yingxin, Yang Xiaoxin, Ran Bingyu, Cao Mingrong, Li Chengzhi, Xu Hao, Gong Jian
Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Department of Hepatological Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Quant Imaging Med Surg. 2025 Jul 1;15(7):6272-6286. doi: 10.21037/qims-24-2232. Epub 2025 Jun 27.
Y microsphere selective internal radiation therapy (Y-SIRT) has been widely used for the treatment of unresectable primary or metastatic liver tumors. Tc-macroaggregated albumin single-photon emission computed tomography-computed tomography (Tc-MAA SPECT/CT) and Y positron emission tomography-computed tomography (Y PET/CT) are performed before and after Y-SIRT, respectively, for pretreatment dose distribution assessment and posttreatment verification of microsphere distribution. The purpose of this study was to evaluate the predictive value of Tc-MAA SPECT/CT for dose distribution assessment and analyze its potential impact on the calculation of absorbed dose to normal liver tissue. To achieve this, the differences in tumor imaging, liver tumor-to-normal ratio (TNR), and normal liver tissue absorbed dose (Dliver) between Tc-MAA SPECT/CT and Y PET/CT were analyzed.
Thirty-eight patients with primary or metastatic liver cancer who underwent Y-SIRT were retrospectively enrolled. Their Tc-MAA SPECT/CT and Y PET/CT images were analyzed, and the TNR measured by Tc-MAA SPECT/CT (TNR) and Y PET/CT (TNR) was compared. The absolute differences in TRN (ΔTNR) and percent differences in TNR (%TNR) between the two values were also calculated. Correlation analysis was conducted with patient's age, body mass index, total liver volume, and target tumor volume. The absolute differences in D (ΔD) and percent differences in D (%D) as calculated by TNR and TNR were respectively compared.
TNR and TNR were not significantly different across imaging modes (P=0.118) and were highly correlated (r=0.854; P<0.01). When stratification by tumor type (primary: n=27; metastatic: n=37) and location (left lobe: n=20; right lobe: n=44) was applied, significant TNR differences emerged only in the left-lobe group (TNR 5.9 TNR 4.7; P=0.015). Bland-Altman analysis demonstrated good agreement in both total and subgroup TNR measurements. The mean ΔTNR was 0.4±1.7, with %TNR ≤92.1%. Dliver calculations showed no significant intermodal difference (P=0.198). Analyses of ΔD and %D revealed maximum overestimations of 37.3 Gy (ΔD >0) and underestimations of 44.5 Gy (ΔD <0), with peak %D reaching 92.0%.
Comparison with Y PET/CT imaging indicated that Tc-MAA SPECT/CT could accurately reflect TNR and D in Y-SIRT. However, TNR may have the tendency to overestimate the true TNR, and appropriate dose adjustments should be considered during treatment planning. The differences in TNR observed in the left-lobe group and the potential differences in the primary group should be further analyzed in larger-sample studies.
钇微球选择性内放射治疗(Y-SIRT)已广泛用于治疗不可切除的原发性或转移性肝肿瘤。分别在Y-SIRT治疗前和治疗后进行锝标记大聚合人血清白蛋白单光子发射计算机断层扫描-计算机断层扫描(Tc-MAA SPECT/CT)和钇正电子发射断层扫描-计算机断层扫描(Y PET/CT),用于治疗前剂量分布评估和微球分布的治疗后验证。本研究的目的是评估Tc-MAA SPECT/CT在剂量分布评估中的预测价值,并分析其对正常肝组织吸收剂量计算的潜在影响。为此,分析了Tc-MAA SPECT/CT和Y PET/CT在肿瘤成像、肝肿瘤与正常组织比值(TNR)以及正常肝组织吸收剂量(Dliver)方面的差异。
回顾性纳入38例接受Y-SIRT治疗的原发性或转移性肝癌患者。分析他们的Tc-MAA SPECT/CT和Y PET/CT图像,并比较通过Tc-MAA SPECT/CT(TNR)和Y PET/CT(TNR)测量的TNR。还计算了两个值之间TRN的绝对差异(ΔTNR)和TNR的百分比差异(%TNR)。对患者的年龄、体重指数、全肝体积和靶肿瘤体积进行相关性分析。分别比较由TNR和TNR计算得出的D的绝对差异(ΔD)和D的百分比差异(%D)。
不同成像模式下的TNR和TNR无显著差异(P = 0.118),且高度相关(r = 0.854;P < 0.01)。按肿瘤类型(原发性:n = 27;转移性:n = 37)和位置(左叶:n = 20;右叶:n = 44)分层时,仅左叶组出现显著的TNR差异(TNR 5.9 TNR 4.7;P = 0.015)。Bland-Altman分析表明,总体和亚组TNR测量结果具有良好的一致性。平均ΔTNR为0.4±1.7,%TNR≤92.1%。Dliver计算显示不同模式间无显著差异(P = 0.198)。对ΔD和%D的分析显示,最大高估为37.3 Gy(ΔD > 0),最大低估为44.5 Gy(ΔD < 0),峰值%D达到92.0%。
与Y PET/CT成像比较表明,Tc-MAA SPECT/CT能够准确反映Y-SIRT中的TNR和D。然而,TNR可能有高估真实TNR的趋势,在治疗计划制定过程中应考虑进行适当的剂量调整。左叶组观察到的TNR差异以及原发性组的潜在差异应在更大样本研究中进一步分析。